Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-06-30
2009-08-25
Lukton, David (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S402000, C530S324000, C530S345000, C514S002600
Reexamination Certificate
active
07579444
ABSTRACT:
Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates.
REFERENCES:
patent: 4770999 (1988-09-01), Kaufman et al.
patent: 5460950 (1995-10-01), Barr et al.
patent: 5567422 (1996-10-01), Greenwald
patent: 5621039 (1997-04-01), Hallahan et al.
patent: 5629384 (1997-05-01), Veronese et al.
patent: 5637749 (1997-06-01), Greenwald
patent: 5714583 (1998-02-01), Foster et al.
patent: 5770700 (1998-06-01), Webb et al.
patent: 5925738 (1999-07-01), Miekka et al.
patent: 5965425 (1999-10-01), Barr et al.
patent: 5969040 (1999-10-01), Hallahan et al.
patent: 6037452 (2000-03-01), Minamino et al.
patent: 6048720 (2000-04-01), Dalborg et al.
patent: 6320029 (2001-11-01), Miekka et al.
patent: 6372716 (2002-04-01), Bush et al.
patent: 6423826 (2002-07-01), Nelsestuen
patent: 6566506 (2003-05-01), Greenwald et al.
patent: 7125843 (2006-10-01), DeFrees et al.
patent: 2004/0106779 (2004-06-01), Bigler et al.
patent: 2004/0180054 (2004-09-01), Kim et al.
patent: 2005/0063943 (2005-03-01), Sommermeyer et al.
patent: 2005/0100982 (2005-05-01), DeFrees et al.
patent: 2005/0176108 (2005-08-01), Kim et al.
patent: 94/04193 (1994-03-01), None
patent: 94/18247 (1994-08-01), None
patent: 97/11957 (1997-04-01), None
patent: 03/040211 (2003-05-01), None
patent: PCT/US2005/023745 (2007-01-01), None
Caliceti (Adv Drug Delivery Rev 55, 1261-1277, 2003).
ENZON Pharmaceuticals, Macromolecular Engineering Technologies, pp. 1-14, (2004).
Nektar™ —Transforming Therapeutics, Nektar Molecule Engineering: Polyethylene Glycol and Derivatives for Advanced PEGylation, pp. 1-20, (Catalog—2003).
Nektar™ —Transforming Therapeutics, Nektar Molecule Engineering: Polyethylene Glycol and Derivatives for Advanced PEGylation, 1-24, (Catalog—2004).
NOF Corporation, “PEG Derivatives Phospholipid and Drug Delivery Materials for Pharmaceuticals”, pp. 1-46, (Catalogue 2003-1st).
NOF Corporation, “PEG Derivatives Phospholipid and Drug Delivery Materials for Pharmaceuticals”, p. 1-46, (Catalogue 2003-2nd).
Polypure, Products; PEG amines; PEG acids and amino acids; PEG thiols and disulfides; Biotins, (Apr. 2004).
Polypure, Products; PEG amines; PEG acids and amino acids; PEG thiols and disulfides; Biotins, (Apr. 2005).
Quanta Biodesign, Labeling, Derivatization and Crosslinking Reagents for Biological and Related Materials with dPEG™, p. 1-38, (Mar. 12, 2004).
Quanta Biodesign, Labeling, Modification and Crosslinking Reagents incorporating our unique momodispersed dPEG™ Technology, p. 1-31, (Nov. 5, 2004).
Shearwater Polymers, Inc., p. 2-42, & 49 (Catalog—Mar. 1995).
Shearwater Polymers, Inc., Polyethylene Glycol and Derivatives, p. 1-53, (Catalog—1997-1998).
Shearwater Polymers, Inc., Polyethylene Glycol and Derivatives, p. 1-50, (Catalog—2000).
Shearwater Corporation, Polyethylene Glycol and Derivatives for Biomedical Applications, p. 1-17, (Catalog—2001).
Veronese, “Peptide and protein PEGylation—a review of problems and solutions”, Biomaterials, 22(5):405-417, (2001).
European Patent Office Comminication dated Jan. 22, 2008 in European Patent Application No. 05 767 845.0.
Bossard Mary J.
Stephenson Gayle
Lukton David
Nektar Therapeutics AL, Corporation
Wilson Mark A.
LandOfFree
Polymer-factor IX moiety conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymer-factor IX moiety conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymer-factor IX moiety conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4058557